Literature DB >> 27114324

Are industry financial ties associated with greater scholarly impact among academic otolaryngologists?

Peter F Svider1, Michael Bobian1, Ho-Sheng Lin1,2,3,4,5, Michael Setzen6,7, Soly Baredes8,9, Jean Anderson Eloy8,10,11,9, Adam J Folbe1,3.   

Abstract

OBJECTIVES/HYPOTHESIS: In response to concerns regarding physician-industry relationships, the Physician Sunshine Act of 2010 was passed in an effort to increase transparency and accountability. Our objective was to determine whether there is an association between industry support and scholarly impact among academic otolaryngologists.
METHODS: Faculty listings, academic rank, and fellowship training of academic otolaryngologists were accessed from departmental websites. H-indices, number of publications, and publication range (years) of each individual were calculated using the Scopus database. The Center for Medicare and Medicaid Services Open Payments database was used to determine industry payments during 2014 to each otolaryngologist.
RESULTS: Of 1,515 otolaryngologists, 65.4% received industry support and 15.8% received support > $1,000. No difference in impact, as measured by the h-index, was noted upon comparison of those receiving support and those who did not (P > 0.05). Individuals receiving > $1,000 had higher h-indices and total publications than those receiving < $1,000 or receiving no support (H = 17.8 vs. 10.9, P < 0.0001), even upon controlling for academic seniority. Upon organization by subspecialty, individuals receiving > $1,000 had greater scholarly impact among most subspecialties. Industry contributions increased with advancing experience.
CONCLUSION: Receiving industry contributions greater than $1,000 is associated with greater scholarly impact among academic otolaryngologists. In a smaller surgical specialty, such as otolaryngology-head and neck surgery, direct industry research support-as well as indirect contributions through the support of educational programs, consulting, and other expenses-potentially impacts scholarly discourse; these findings do not reflect a causal relationship and may require further characterization. LEVEL OF EVIDENCE: NA Laryngoscope, 127:87-94, 2017.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Keywords:  Industry relationships; h-index; industry contributions; pharmaceutical company; scholarly impact

Mesh:

Year:  2016        PMID: 27114324     DOI: 10.1002/lary.26027

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Association of Gender With Financial Relationships Between Industry and Academic Otolaryngologists.

Authors:  Jean Anderson Eloy; Michael Bobian; Peter F Svider; Ashley Culver; Bianca Siegel; Stacey T Gray; Soly Baredes; Sujana S Chandrasekhar; Adam J Folbe
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-08-01       Impact factor: 6.223

2.  Association of Compensation From the Surgical and Medical Device Industry to Physicians and Self-declared Conflict of Interest.

Authors:  Kasra Ziai; Alessio Pigazzi; Brian R Smith; Roxana Nouri-Nikbakht; Helene Nepomuceno; Joseph C Carmichael; Steven Mills; Michael J Stamos; Mehraneh D Jafari
Journal:  JAMA Surg       Date:  2018-11-01       Impact factor: 14.766

3.  Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.

Authors:  Susan F Wood; Joanna Podrasky; Meghan A McMonagle; Janani Raveendran; Tyler Bysshe; Alycia Hogenmiller; Adriane Fugh-Berman
Journal:  PLoS One       Date:  2017-10-25       Impact factor: 3.240

4.  Analysis of payments to GI physicians in the United States: Open payments data study.

Authors:  Venu Gopala Reddy Gangireddy; Rajan Amin; Kevin Yu; Praveen Kanneganti; Swathi Talla; Amarnath Annapureddy
Journal:  JGH Open       Date:  2020-08-21

Review 5.  Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review.

Authors:  Tom Latten; Daan Westra; Federica Angeli; Aggie Paulus; Marleen Struss; Dirk Ruwaard
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.